Cardlytics Statistics
Total Valuation
Cardlytics has a market cap or net worth of $412.22 million. The enterprise value is $582.08 million.
| Market Cap | 412.22M |
| Enterprise Value | 582.08M |
Important Dates
The next estimated earnings date is Tuesday, July 30, 2024, after market close.
| Earnings Date | Jul 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cardlytics has 48.78 million shares outstanding. The number of shares has increased by 17.76% in one year.
| Shares Outstanding | 48.78M |
| Shares Change (YoY) | +17.76% |
| Shares Change (QoQ) | +9.64% |
| Owned by Insiders (%) | 5.65% |
| Owned by Institutions (%) | 74.97% |
| Float | 41.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.32 |
| Forward PS | 1.21 |
| PB Ratio | 2.07 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 1.34.
| Current Ratio | 2.13 |
| Quick Ratio | 2.04 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.84 |
Financial Efficiency
Return on equity (ROE) is -86.80% and return on invested capital (ROIC) is -33.66%.
| Return on Equity (ROE) | -86.80% |
| Return on Assets (ROA) | -28.60% |
| Return on Capital (ROIC) | -33.66% |
| Revenue Per Employee | $720,002 |
| Profits Per Employee | -$397,661 |
| Employee Count | 434 |
| Asset Turnover | 0.52 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.83% in the last 52 weeks. The beta is 1.66, so Cardlytics's price volatility has been higher than the market average.
| Beta (5Y) | 1.66 |
| 52-Week Price Change | -16.83% |
| 50-Day Moving Average | 8.79 |
| 200-Day Moving Average | 9.70 |
| Relative Strength Index (RSI) | 48.36 |
| Average Volume (20 Days) | 687,511 |
Short Selling Information
The latest short interest is 7.70 million, so 15.79% of the outstanding shares have been sold short.
| Short Interest | 7.70M |
| Short Previous Month | 7.11M |
| Short % of Shares Out | 15.79% |
| Short % of Float | 18.60% |
| Short Ratio (days to cover) | 9.08 |
Income Statement
In the last 12 months, Cardlytics had revenue of $312.48 million and -$172.59 million in losses. Loss per share was -$4.60.
| Revenue | 312.48M |
| Gross Profit | 136.75M |
| Operating Income | -157.11M |
| Pretax Income | -172.59M |
| Net Income | -172.59M |
| EBITDA | -140.93M |
| EBIT | -169.44M |
| Loss Per Share | -$4.60 |
Balance Sheet
The company has $97.77 million in cash and $267.63 million in debt, giving a net cash position of -$169.86 million or -$3.48 per share.
| Cash & Cash Equivalents | 97.77M |
| Total Debt | 267.63M |
| Net Cash | -169.86M |
| Net Cash Per Share | -$3.48 |
| Equity (Book Value) | 199.14M |
| Book Value Per Share | 4.08 |
| Working Capital | 115.71M |
Cash Flow
In the last 12 months, operating cash flow was -$7.74 million and capital expenditures -$14.34 million, giving a free cash flow of -$22.08 million.
| Operating Cash Flow | -7.74M |
| Capital Expenditures | -14.34M |
| Free Cash Flow | -22.08M |
| FCF Per Share | -$0.51 |
Margins
Gross margin is 43.76%, with operating and profit margins of -50.28% and -55.23%.
| Gross Margin | 43.76% |
| Operating Margin | -50.28% |
| Pretax Margin | -55.23% |
| Profit Margin | -55.23% |
| EBITDA Margin | -45.10% |
| EBIT Margin | -54.22% |
| FCF Margin | -7.06% |
Dividends & Yields
Cardlytics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.76% |
| Shareholder Yield | -17.76% |
| Earnings Yield | -41.87% |
| FCF Yield | -5.36% |
Analyst Forecast
The average price target for Cardlytics is $12.67, which is 49.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.67 |
| Price Target Difference | 49.94% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cardlytics has an Altman Z-Score of -2.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.31 |
| Piotroski F-Score | 4 |